Breaking down the barriers: fMRI applications in pain, analgesia and analgesics

1744-8069-2-30 1744-8069 Review Breaking down the barriers: fMRI applications in pain, analgesia and analgesics Borsook David dborsook@mclean.harvard.edu Becerra R Lino lbecerra@mclean.harvard.edu

P.A.I.N. Group, Brain Imaging Center, Department of Psychiatry, McLean Hospital, Belmont, MA, USA

Athinoula Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, MA, USA

Molecular Pain 1744-8069 2006 2 1 30 http://www.molecularpain.com/content/2/1/30 16982005 10.1186/1744-8069-2-30 26 7 2006 18 9 2006 18 9 2006 2006 Borsook and Becerra; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

This review summarizes functional magnetic resonance imaging (fMRI) findings that have informed our current understanding of pain, analgesia and related phenomena, and discusses the potential role of fMRI in improved therapeutic approaches to pain. It is divided into 3 main sections: (1) fMRI studies of acute and chronic pain. Physiological studies of pain have found numerous regions of the brain to be involved in the interpretation of the 'pain experience'; studies in chronic pain conditions have identified a significant CNS component; and fMRI studies of surrogate models of chronic pain are also being used to further this understanding. (2) fMRI studies of endogenous pain processing including placebo, empathy, attention or cognitive modulation of pain. (3) The use of fMRI to evaluate the effects of analgesics on brain function in acute and chronic pain. fMRI has already provided novel insights into the neurobiology of pain. These insights should significantly advance therapeutic approaches to chronic pain.

Background: 'O (Chronic) Pain Miserum'

At least two major hurdles remain in the treatment of chronic pain. The first is that no objective test for pain currently exists. A blood test, genetic marker or psychophysical measure would greatly improve diagnosis of chronic pain. The second is the lack of an "antibiotic equivalent" (i.e., drugs with high sensitivity and specificity) for the treatment of chronic pain subtypes (e.g., neuropathic pain). Controlled trials of drug efficacy indicate that, on average, the most effective drugs of different classes have similar efficacy (around 30% greater than placebo) across neuropathic conditions 123. Analgesic use is dictated by both efficacy and adverse side effects and side effects can sometimes take precedence over efficacy 4. A lack of controlled trials for other methods of pain treatment (interventional, psychological, physical therapy) makes it difficult for physicians to evaluate these possible therapies. As a result, chronic pain treatment is difficult, and physicians and patients often resort to using multiple treatments simultaneously or sequentially in the effort to achieve pain relief. Unfortunately, even a combined therapeutic approach frequently offers little benefit (Figure 1).

Figure 1

The problem with chronic pain

The problem with chronic pain. Therapy for acute pain (e.g., acute inflammation, trauma, post-surgical pain) is overall excellent. However, in chronic pain (e.g., neuropathic pain, fibromyalgia, complex regional pain syndrome), therapy is poor. This group thus falls into a zone (circles) of "therapeutic failure" or "therapeutic impasse" where multiple therapies are tried with overall little success. Functional imaging appears poised to open up new approaches to the understanding of chronic pain conditions. An improved basic understanding of the mechanisms underlying chronic pain is likely to suggest new avenues for the development of novel pharmacotherapies.

Recent advances in functional imaging have revolutionized our concept of central process of pain. Indeed, it seems that we are on the verge of using this technology to reach a fundamental new understanding of clinical pain, particularly chronic pain (defined as pain lasting for more than 6 months). Subdivision of chronic pain syndromes into chronic neuropathic pain (e.g., phantom pain, post-herpetic neuralgia), chronic nociceptive pain (e.g., arthritis, migraine), and a group comprising very poorly understood categories of pain (e.g., fibromyalgia, depression-induced pain, or complex regional pain syndrome) has not clarified mechanistic processes. Even classification of chronic pain types based on clinical disease (e.g., cancer pain, diabetic pain) has not proved very helpful in understanding the mechanisms underlying chronic pain. Recently a mechanistic approach to defining pain has been suggested in which specific pain phenotypes such as shooting pain, burning pain, and allodynia can be applied across pain types such as neuropathic pain. 5. However, this approach is based primarily on an understanding of peripheral nerve and spinal cord processing. Functional imaging has already redefined chronic pain as a degenerative disease, and has shed some light on complex diseases such as fibromyalgia 6. Since brain responses are the final common pathway in behavioral responses to pain (unconscious and conscious), we believe that the application of functional imaging will allow us to categorize pain conditions in an objective manner and to better understand the underlying circuitry and identify targets for a new generation of analgesics 78.

fMRI measures neural activity by an indirect evaluation of changes in blood flow in capillary beds 9. A number of approaches including block design 10, event-related 11, and percept-related. 12 paradigms, have been applied to fMRI studies of physiological, clinical and pharmacological aspects of pain and analgesia. Application of baseline measures of spontaneous pain have allowed the "basal state" to be evaluated.) 13. Issues pertaining to the validity of fMRI in pain and analgesic measures have been presented elsewhere 14.

"To consider only the sensory features of pain, and ignore its motivational and affective properties, is to look at only part of the problem, not even the most important part at that." This statement of Melzack and Casey's 15 was an early recognition of these aspects of pain, but their importance is now widely accepted. The ability to use fMRI to image the whole brain at the same time and to use powerful algorithms to segregate functional circuits allows us to begin to elucidate the CNS processes underlying affective and motivational components of pain. It also allows a broader window to observe potential CNS sites of drug action. Our understanding of 'difficult' disease states (e.g., fibromyalgia or depression-related pain), the placebo response, emotional responses (e.g., empathy), and acupuncture will clearly be influenced by new insights into how emotional circuitry in the brain functions in pain states and in responses to analgesics. 16. In this paper, we review the contribution of fMRI to the understanding of acute and chronic pain, its use in surrogate models and for evaluation of endogenous pain systems including the placebo response, and its potential use as an objective measure of analgesic efficacy. The approach we have taken to summarize the new advances has been to provide an overview for each domain (e.g., Acute and Chronic pain, Endogenous Systems etc.) and summary tables that focus on specific areas within each domain (e.g., Chronic pain: Neuropathic, Fibromyalgia etc.). Studies listed are predominantly from peer-reviewed journals (Data Sources: Medline) or data from our own lab presented at Society for Neuroscience and/or in press. We attempted to include primary examples on specific entities of CNS processing as defined with fMRI that are related to pain, analgesia and analgesics.

Advancing our Understanding of CNS Mechanisms in Acute and Chronic Pain through fMRI

fMRI of Physiological Pain – a new understanding of brain regionsinvolved in pain processing in humans

Much of the work in fMRI of pain has utilized thermal stimuli (contact peltier thermodes or laser) to activate pain circuits. Other types of stimuli, including electrical and mechanical (pressure) have not been as extensively used either in the intact system or where sensitization has been experimentally induced (see Table 3). The accumulation of data has begun to identify brain regions involved in pain processing – from peripheral ganglia to central limbic and brainstem structures previously only implicated in animal studies in the preclinical literature (see Table 1).

Table 3

Examples fMRI Studies of Surrogate Models of Pain

STUDY FOCUS

REFERENCE

MAJOR FINDINGS

COMMENT

Experimental Allodynia

Capsaicin induced secondary hyperalgesia

Baron et al., 1999 [81]

9 Subjects. Capsaicin injection induced secondary mechanical hyperalgesia. Painful mechanical stimulation produced activation in prefrontal cortex >> than in nonpainful mechanical stimulation

First fMRI study of capsaicin induced hypersensitivity. Activation in prefrontal cortex = attention and cogniitvie changes (e.g., planning).

Brainstem activation by capsaicin

Zambreanu et al., 2005 [82]

Heat-capsaicin model used. Punctate mechanical stimuli applied to region of secondary hyperalgesia. Stimuli in hyperalgesic vs. control region showed activation in contralateral brainstem, cerebellum, bilateral thalamus, contralateral SI and SII, middle frontal gyrus, parietal association cortex and brainstem (cuneiformis, superior colliculi, PAG.

First evaluation of contribution of brainstem in central sensitization.

Cognitive influences on hyperalgesia

Wiech et al., 2005. [83]

Capsaicin-induced heat hyperalgesia results in frontal and medial prefrontal cortex, insula, and cerebellum. Activity in medial prefrontal cortex and cerebellum modulated by cognitive task.

Study addresses interaction between motivational and cognitive functions and may provide some basis for evaluating similar changes in chronic pain.

Capsaicin allodynia

Maihofner et al., 2004. [39]

Region of allodynia produced by capsaicin and thermal kindling. Brush to normal skin results in SI, parietal association cortex, SII bilaterally, contralateral insula. Brush to allodynic skin resulted in some overlap to those observed for control in addition to inferior frontal cortex, and ipsilateral insula.

Subtraction (unaffected vs. affected skin) indicates that mechanical allodynia in regions that include SI, parietal association cortex, inferior frontal cortex, and insula.

Definitions of terms in Table 3

Allodynia – pain to a normally non-noxious stimulus.

Central Sensitization – increased sensitivity or excitability in central pain pathways as a result of increase in sensitivity/activation of these neural systems

Hyperalgesia – An increased response to a stimulus that is normally painful

Secondary Hyperalgesia – pain outside of the area of the primary injury.

Table 1

Examples of Contributions by fMRI on the understanding Brain Regions activated by Acute Pain

STUDY FOCUS

REFERENCE

MAJOR FINDINGS

COMMENT

Peripheral Nerve

Trigeminal Ganglion (TG)

Borsook et al., 2003. [63]

Somatotopic activation in the trigeminal ganglion

Measures of the peripheral nervous system may be evaluated using fMRI

Dorsal Horn

Trigeminal Nucleus (TN)

DaSilva et al., 2002. [20]

Somatotopic acitivation in the TN

Study reports that pain spinal cord brainstem systems can be defined and somatotopically evaluated.

Brainstem

Periaqueductal Gray (PAG)

Becerra et al., 2001 [17]

Both increases (early) and decrease (late) of activation may correlate with ascending and descending (modulatory) components of functioning within this structure.

The PAG is a 'core' structure in understanding how the brain modulates pain, both in placebo and in the effects of analgesics, particularly opioids.

Right Cuneus

Fulbright et al., 2001 [64]

Cold pressor induced pain produced activation in a number of regions including the frontal lobe and the cuneus.

Measures of affective components of cold pain.

Brainstem NucleiCuneiformis, parabrachial, PAG, red nucleus

Dunckley et al., 2005 [65]

Activation to somatic and visceral pain.

A big step forward in measures of brainstem measures of pain in humans. Marked similarities in the two processes were observed at a brainstem level.

Subcortical Gray Regions

Emotion CircuitryAccumbens, SLEA, Amygdala, Hippocampus, Hypothalamus, Oribitofrontal Cortex

Becerra et al., 2001 [17]

Acute pain activates circuitry that is commonly associated with reward. Emotional circuitry is activated ahead of sensory circuitry

The first demonstration that reward circuitry can be mapped in acute pain.

Amygdala

Seymour et al., 2005 [21]

Termination of pain (rewarding) activates the amygdala

The significance of understanding the brain systems to natural reward (i.e., pain relief).

Putamen

Bingel et al., 2004 [66]

15 Subjects. Laser evoked pain to foot or hand produced contralateral somatotopic organization in putamen

Clear activation in putamen by pain indicative of potential role in emotional or motor processing of pain.

Accumbens (NAc)

Aharon et al., 2006 [18]

Acute noxious (but not non-noxious) stimuli activate the NAc. Within the structure, different signals may indicate functional processing within the 'core' and 'shell' of the structure.

A number of regions have different functional components (e.g., amygdala, PAG) and the ability to dissect apart these within a set paradigm will contribute further to mechanistic functions of pain processing in humans.

Cortical Regions

Anterior Cingulate(aCG)

Becerra et al., 1999 [10], 2001 [17]

One of the first fMRI studies to demonstrate differential aCG activation in the structure.

Differentiation of sensory vs. emotional components of aCG function.

Hippocampus (Hi)

Ploghaus et al., 1999 [27], 2000 [67], 2001 [28]

Hippocampal activation correlates with anxiety/

Papers address a specific function of the hippocampus in pain and further show a correlation with insula activity.

Insula (I)

Brooks et al., 2005. [19]

Somatotopic organization in the insula defined

The insula has been a bit of an enigma. Based on preclinical work, human work seems to support the notion that the insula is receives thermal information from the ventromedial nucleus of the thalamus (VMpo) specific thermal stimuli

Oribtofrontal Cortex (GOb)

Rolls et al., 2003. [68]

Effects of pleasant and painful touch to hand. Oribitofrontal activation > pleasant or pain vs. neutral. SI less activated by pleasant and pain than neutral touch. Regional differences in aCG to pleasant (rostral aCG) and pain (posterior dorsal). Brainstem (e.g., PAG) activated by all 3 touch stimuli.

Clear dissociation between sensory and emotional systems to 'reward' and aversion.

Somatosensory Cortex

Bingel et al., 2004 [66]

Painful laser stimuli applied to hand and foot produced somatotopic organization in contralateral and ipsilateral SI cortex.

Laser stimuli can provide stimuli without tactile components.

Some of these regions are part of well-defined pain circuits (e.g., PAG, parabrachial nuclei) while for others such as the nucleus accumbens, their specific role in pain processing is not well understood 1718. Studies have reported specificity of somatotopic organization of structures outside of the primary somatosensory cortex involved in pain processing in humans; these such as the insula 19 and the trigeminal system 1420. Indeed, the results of human imaging help focus attention on specific regions, including the nucleus accumbens (involved in emotional salience), the insula (involved in specific interpretation of noxious stimuli) or the amygdala (involved in fear), opening new vistas for understanding how the human brain evaluates pain. The ability to evaluate activity and organize active regions into neural circuits that subserve specific pain/analgesia functions (i.e., sensory, emotional, autonomic, endogenous analgesic circuits) is a step forward. A number of studies have already begun this task including segregation of function within a structure (e.g., PAG 17 and NAc 18), defining analgesia as a rewarding process 21, and functional differentiation of activation sites within a particular brain region (e.g., cognitive and affective regions within the anterior cingulate 17).

What is needed now is to further evaluate these brain areas, some of whose role is newly defined in pain processing in humans, at a functional level. Several new fMRI approaches will aid this effort including techniques that allow definition of large scale systems organization 22; techniques that define circuits/functional connectivity 23; and automated parcellation of brain structures 2425 including the thalamus 26. Imaging studies have not only unveiled new regions involved in pain processing, but have also contributed new insights into the functioning of these regions in experimental pain. For example, the hippocampus, classically associated with memory, has been shown to be involved in pain-induced anxiety 272829.

fMRI of Chronic Pain

Imaging clinical conditions is fraught with issues that make it more challenging, including the fact that it is difficult to assemble a cohort with similar symptoms, duration of disease, medication history, age distribution, etc. Among clinical conditions, chronic pain has a particularly wide spectrum of patient presentations and medical histories. However, studies have begun to evaluate CNS changes that occur in patients with chronic pain (see review by Apkarian and colleagues 30), including those with neuropathic pain, fibromyalgia, complex regional pain syndrome and visceral pain (Table 2).

Table 2

Examples of Contributions of fMRI to the understanding of CNS circuitry underlying Chronic Pain

STUDY FOCUS

REFERENCE

MAJOR FINDINGS

COMMENT

Neuropathic Pain

Mechanical Allodynia

Peyron et al., 2004. [69]

Activated regions mirror control network activated by brush, cold to the normal side. Regions activated include SI, SII and insula.

Study tackles an issue of ongoing pain and the problems associated with ongoing background pain.

Back Pain vs. Postherpetic Neuropathy

Apkarian et al., 2004. [34]

A potentially huge step forward in the use of fMRI to differentiate chronic pain subtypes.

Trigeminal Neuropathy

Becerra et al., 2005 [33] Becerra et al., 2006 [70]

V2 neuropathy patients evaluated in a repeat study for mechanical (brush) and thermal (cold and heat) stimuli.

Mechanistic changes in CNS function to specific stimuli.

Chronic Back Pain

Giesecke et al., 2004. [31]

Heterotopic pressure stimulus applied to the thumb activates a number of brain regions.

Generalized increase in pain sensitivity in chronic pain; pain >> in patients than controls for the same pressure stimulus. Equally painful stimuli produced similar brain activations.

Spinal Cord Injury (SCI)

Nicotra et al., 2005 [71]

Seven patients with SCI evaluated including painful stimuli (shock) in an aversive paradigm. Conditioning stimuli produces enhancement of activity in dorsal anterior cingulated, PAG and superior temporal gyrus to conditioning stimuli and attenuation in subgenual aCG, ventromedial prefrontal and posterior cingulated to threat of shock.

The study is able to dissect apart possible changes in the brains of SCI patients, including central sensitization and alterations in affective components of the brain (subgenual aCG) that may be part of a disturbance of affective and autonomic processing.

Unpleasant Odor

Villemure et al., 2005 [72]

Single patient with neuropathic pain where pain increased when exposed to experimental odors in thalamus, amygdala, aCG and SI.

This study may suggest subcortical mechanisms of aversion have a common neural circuitry.

Complex Regional Pain Syndrome

Pediatric CRPS

Lebel et al., 2005. [73]

Pediatric group with relapsing CRPS of lower extremity. Changes to cold most predominant.

Clinical models within particular groups of diagnosis may be used to determine the etiology of more chronic conditions e.g., adult CRPS.

Mechanical Allodynia in Adult CRPS

Maihofner et al., 2005 [40]

Twelve Patients. Pin-prick hyperalgesia activates a number of cortical regions (SI, SII, Insula, aCG, frontal cortex).

Study focus is on cortical regions only and indicates significant changes in functioning in affected vs., unaffected. No control group.

Sympathetically Maintained Pain (SMP)

Apkarian et al., 2001. [74]

Evaluation of stimuli to painful site before and after sympathetic blockade. SMP associated with increased prefrontal, aCG activation and decrease in contralateral thalamus.

Correlates of CNS function shown:ineffective blocks did not change cortical activityplacebo response same as effective block

Fibromyalgia

Primary fibromyalgia (FM)

Cook et al., 2004 [75]

Fibromyalgia compared with control group. Fibromyalgia group more sensitive on psychophysical evaluation. Non-painful stimuli produced greater activation in a number of regions including prefrontal, SMA, insula and cingulated cortices. Pain produced greater activation in the contralateral insula in (FM) patients.

Central changes with increased sensitivity/hyperalgesia are clearly manifest behaviorally and on fMRI. Such insights provide a new approach to understanding a heretofore ill- defined disease.

Catastrophizing

Gracely et al., 2004 [6]

Pressure stimulus applied to the thumb (i.e., heterotopic). SII activation >> in high catasrophizers; contralateral aCG and bilateral lentiform nucleus. This was independent of depression.

Catastrophizing may contribute to the pain state by enhancing the emotional reaction to pain.

Visceral Pain

Functional bowel disorder

Kwan et al., 2005 [76]

Healthy (11) vs. Patients (9) underwent painful rectal distention. Activation in the medial thalamus, hippocampus for pain.

On line ratings of pain responses. – clear differences in emotional circuitry of medial thalamus and hippocampus.

Irritable Bowel Syndrome (IBS) with constipation vs. diarrhea

Wilder-Smith et al., 2004 [77]

Female healthy (10) and IBS (10; 5-constipated and 5-diarrhea) underwent rectal distention and painful heterotopic pain applied to activate DNIC. Significant differences in CNS regions (prefrontal cortex, amygdala, aCG, PAG, Hippocampus) between constipated and diarrhea groups and controls.

Different responses in patient subtypes of IBS suggesting differences in endogenous modulatory systems.

Irritable Bowel Syndrome (IBS)

Mertz et al., 2000 [78]

Healthy (16) vs. patients with IBS (18), IBS patients have increased activation in aCG.

Increased central sensitivity to the same type of stimulus.

Visceral and Cutaneous Hypersensitivity in Irritable Bowel Syndrome (IBS)

Verne et al., 2003 [32]

Rectal cutaneous pain produced increased activation in thalamus and SI, I, aCG, pCG and prefrontal cortex.

The brain is adversely affected in chronic pain – both visceral and cutaneous hyperalgesia produced. These findings provide a window on how we may address treatments for these patients.

Irritable Bowel Syndrome (IBS)

Bonaz et al., 2002. [79]

Rectal pain produced in 11 female subjects with IBS. Activation in insula, amygdala and striatal regions. Greater activation in patients in the insula and frontal regions.

Similar to other studies a more complex alteration in pain processing is present in this group of subjects. Issues of variability in patients are still a concern.

Chronic Inflammation

Vulvar vestibulitis

Pukall et al, 2005. [80]

Allodynia measured in patients (14) and controls (14) age and contraceptive matched.

Similar type of changes in patients with IBS, Fibromyalgia.

A number of important issues are emerging in the evaluation of chronic pain conditions as fMRI and associated imaging technologies become more sophisticated. Chronic pain produces changes that become manifest as alterations in the central nervous system. One may term this "centralization of hyperalgesia" or "centralization of pain". This has been evaluated across diseases including fibromyalgia 6, chronic back pain 31, and irritable bowel syndrome 32. During functional imaging of fibromyalgia and chronic back pain, enhanced responses to thermal or mechanical stimuli that are applied heterotopically (i.e., away from the actual location of the pain) are present in a number of CNS regions, including non-sensory regions. Differences in specific responses to brush, heat and cold in affected vs. intact regions in patients with neuropathic pain have also been reported 33. One feature that seems to be of in common with chronic pain patients is significantly greater frontal lobe activation in chronic pain sufferers 30. This feature, suggests that in chronic pain CNS activity in regions involved in cognitive processing differs between acute and chronic pain. These insights are further complicated by the new and revolutionary recognition that, in chronic pain, neuronal loss occurs in significant pain pathways including the thalamus and the lateral prefrontal cortex 34. The role of this neurodegeneration in producing either the altered CNS responses or the pain state is not understood.

Maladaptative changes in non-sensory circuits may contribute to the psychological states, including depression, anxiety and amotivation that are often seen in these patients. Thus the study of specific brain regions such as the nucleus accumbens (involved in probability assessments and reward evaluation), the amygdala (involved in orientating to and the memory of motivationally salient stimuli), the hippocampus (involved in evaluating the expectancy of an unknown condition), the prefrontal cortex (involved in cognitive and planning functions around emotional stimuli or regarding rewarding or aversive outcomes) and the anterior cingulated cortex (involved in the rank ordering of the value or salience of the stimulus) may provide new insights into brain functioning in these co-morbid conditions. Such insights should provide immediate benefits to the understanding of the calcitrant nature of chronic pain to therapeutic interventions.

Our increased recognition that multiple neural systems are involved in pain processing and affect pain perception (reward/aversion circuitry, the role of anticipation, neural systems interpreting different pain types albeit at the same intensity, opponent systems and drug effects) suggests that multiple neural circuitries are likely affected in chronic pain. Results published thus far indicate that: (1) Pain intensity is probably not a good marker for changes in chronic pain state. Neural imaging may be able to define a correlation between CNS activation and patient answers to a simple subjective questionnaire that assesses emotional and other components of pain and suffering; (2) Neural systems interpreting components of the pain response (e.g., emotional, empathy, anticipation etc.) are clearly complex, and we still have no understanding of how these may change in the chronic pain condition; and (3) Standards will need to be applied across imaging facilities in order to interpret and compare data across studies.

fMRI of Human Surrogate Pain Models

Defining valid surrogate models has been a problem in both animal and human models of pain 353637. In human studies, mechanical (heat) or chemical (capsaicin) sensitization of skin and testing in primary and secondary regions affected has been used as a surrogate for neuropathic pain (hyperalgesia/allodynia to thermal and mechanical stimuli) 38. Recently fMRI has been used to evaluate the capsaicin – induced hyperalgesia model (see Table 3). While many of these studies report increased activation in a number of brain regions, some of the more recent studies begin to define the utility of fMRI in dissecting mechanistic changes or insights using this model 394041. These studies demonstrate differences in brain activation in response to stimuli of equivalent pain intensity delivered in sensitized vs. non-sensitized state, providing further evidence that pain intensity by itself is probably not a useful measure of the status of the underlying pain processing circuitry 41. An alternate explanation may be that there are mechanistic differences between these two states. Changes in perceived pain intensity may reflect acute changes in CNS sensory pathways but may not correlate with changes in CNS emotional pathways which may be relevant to an individuals' overall response to pain and may predict future pain conditions. Eventually, fMRI should allow the direct comparison of activation in specific CNS regions in experimental models with the activation seen in patients with neuropathic pain. Comparing such objective measures should allow us to determine where the model differs from the disease and to assess the validity of such models for evaluating potential therapies.

fMRI studies of Endogenous Analgesia

Endogenous modulatory networks can either facilitate or inhibit pain4243. Endogenous analgesia refers to systems that produce the latter. These systems involve a network that includes higher cortical (e.g., anterior cingulate cortex) and subcortical regions (e.g., the amygdala, hypothalamus) that project to brainstem nuclei (periaqueductal gray and raphe nuclei) that send projections to the dorsal horn 44 These systems can be modulated by a number of factors including stress, pain and the placebo response 42.

A number of studies have used fMRI to investigate endogenous modulation of pain (Table 4) and map circuits involved in CNS systems that can alter decrease or increase pain 454647. Most of these studies involved attention or distraction to modulate circuits. In addition, closely linked with this are studies of placebo response, evaluation of the effects of attention and expectancy, of empathetic reactions to pain in others, to producing "trickery" of the brain by sensory inputs 48.

Table 4

Examples of Contributions of fMRI on Endogenous Mechanisms of Pain or Analgesia

STUDY FOCUS

REFERENCE

MAJOR FINDINGS

COMMENT

Placebo

Placebo

Wager et al., 2004 [49]

2 studies report that (1) placebo analgesia decreased activation in thalamus, insula aCG and (2) anticipation increased activation in prefrontal cortex

Placebo analgesia may not only decrease pain but may change the affective response to pain.

Placebo in Emotional Processing

Petrovic et al., 2005 [84]

Use of pleasant and unpleasant pictures compared with pain. The same modulatory effect is observed in "emotional" placebo and placebo analgesia (anterior cingulated, lateral orbitofrontal cortex)

Placebo is a process in reward processing.

Placebo analgesia

Bingel et al., 2006 [85]

Nineteen healthy subjects. Placebo analgesia using laser for pain stimulation shows interaction between aCG, amygdala and PAG

Interactions between emotional circuits including the aCG amygdala and affect output processing of endogenous pain control mechanisms.

Attention

Attentional modulation

Tracey et al., 2002 [46]

Nine Subjects. Distraction during painful thermal stimulus. Pain ratings significantly lower with distraction with increased activation in the PAG during this condition.

Specific output of modulatory system via a well-known brain region (i.e., PAG) presumably via inputs from higher cortical regions.

Distraction

Valet et al., 2004 [47]

Stroop task used for distraction during noxious and innocuous heat stimuli. Distraction produced decreases in VAS pain intensity and unpleasantness scores. Distraction increased activation in orbitofrontal cortex, perigenual aCG, PAG and posterior thalamus.

Covariate analysis indicated that the brain may gate information by exerting a top-down effect on PAG and posterior thalamus.

Cognitive Distraction Task

Bantick et al., 2002 [86]

Stroop task used. Intermittent thermal pain applied. Distraction produced increased activation in affective region of the aCG and in the Gob, but decreased activation in pain sensory regions including the cognitive area of the aCG, insula, and thalamus.

Dissection of the effects of distraction on emotional/affective vs. sensory systems in a distraction paradigm.

Virtual Reality Distraction

Hoffman et al., 2004. [87]

Virtual reality decreased pain; both psychophysical ratings and brain activity in aCG, SI, SII, insula and thalamus.

Distraction has not been used in fMRI studies of chronic pain.

Attention to 'location' and 'unpleasantness'

Kulkarni et al., 2005 [88]

Attention to location – activity in SI and inferior parietal cortex. Attention to unpleasantness – activation reported in aCG, orbitofrontal and frontal cortex, amygdala, hypothalamus and

Study focus is on how attention can significantly modulate pain processing.

Miscellaneous

Empathy pain activates affective but not sensory pain

Singer et al., 2004. [89]

Empathy evaluated by subject in magnet observing loved one receive similar painful stimulus (empathetic pain). Activation in insular, aCG, brainstem and cerebellum by both direct or empathetic pain.

Activation in affective circuits not sensory – this may be further support for affective circuits being a focus of study in chronic pain.

Pain and Social Loss

Panksepp, 2003 [90]

Evaluation of social exclusion (rejection). Activation in aCG and ventral prefrontal cortex > with exclusions

Commonality of physical pain response and emotional rejection/hurt?

Salience of Painful Stimuli

Downar et al., 2003 [91]

Sustained pain and non-painful electrical stimulation. Transient activation during 'on' and 'off' of non-painful stimuli in aCG, inferior frontal, temporoparietal regions to non-painful. Same regions in addition to thalamus and putamen showed sustained response during painful stimulus.

Basal ganglia play a role in sustained salience.

Expectancy orAnticipation

Dissociation of pain from its anticipation

Ploghaus et al., 1999 [27]

Expectation of pain produced activation in medial frontal region, insula, and cerebellum. These differed from pain experience.

Emotional/cognitive evaluation of a situation can produce adaptation that can modify the experience. This has enormous implications in the clinical situation e.g., anticipating a procedure. Effects in or on chronic pain are unknown.

Expectation of Pain

Sawamoto et al., 2000 [92]

Expectation increases response to non-painful stimuli in the aCG and posterior insula.

Pain/unpleasantness and pain relief may be opponent processing using similar circuitry.

Expectation of Pain Relief

Seymour et al., 2005. [21]

Activation in the amygdala and midbrain by pain are mirrored by opposite aversion signals in the lateral orbitofrontal cortex and aCG.

Expected vs. Experience Pain

Koyama et al., 2005. [93]

Pain intensity to expected vs. experienced pain evaluated. With increased level of expected pain, activation increased in aCG, insula, thalamus, and prefrontal cortex. Pain experience produced activation in a number of regions (partial overlap with expectancy related pain).

Expectation can modulate the actual experience.

Anticipation of pain

Porro et al., 2002 [94]

Expectation of a pain/no pain stimulus to the foot. Activations increased in contralateral SI but decreased in ipsilateral SI, aCG.

Focus on cortical system

Hypnotically induced (HI) or imagined pain

Derbyshire et al., 2004. [95]

HI pain produced activation in thalamus, aCG, I, prefrontal and parietal cortices.

Pain pathways can be activated without a noxious stimulus. This has implications for understanding CNS processing in chronic pain disorders with no specific etiology.

Expectancy using a conditioning cue

Keltner et al,. 2006 [45]

Pain intensity expectancy acts via a modulatory network that converges on the nucleus cuneiformis (nCF)

A study defining a specific modulatory pathway on this brainstem nucleus.

Paradoxical Sensations

Paradoxical heat

Davis et al., 2004. [48]

When subjects perceived a painful stimulus even though the stimulus was cool or neutral, activation in the right insular cortex was observed.

Sensory inputs in the normal healthy condition can "confuse" the brain. Such insights will be helpful in understanding pain processing in chronic conditions, particularly neuropathic pain.

Prickle sensation

Davis et al., 2002. [12]

Prickle sensation using cold, produced activations present in pain, motor and sensory areas. aCG, SII, prefrontal cortex, caudate, dorsomedial thalamus, prefrontal cortex.

Definition of the utility of percept-related fMRI – i.e., importance of on-line measures of psychophysical data.

Non-dermatomal sensory deficits.

Mailis-Gagnon et al., 2003 [96]

Noxious and non-noxious stimuli were not perceived in these dermatomes (Perceived stimuli activated posterior region of the aCG, thalamus); but produced decreased signal changes in a number of cortical regions (SI, SII, parietal cortex, prefrontal cortex and rostral aCG).

Four Patients tested to evaluate nondermatomal neurosensory deficits. Another insight into evaluating complex patient groups with altered pain processing. fMRI however does provide data in support of a testable neurobiological hypothesis instead of generic labeling of such patients.

Acupuncture

Electroacupuncture vs. manual acupuncture

Napadow et al., 2005 [97]

For regional responses electroacupuncture>manual>placebo. Acupuncture induced increased activations in insula and decreased activations in amygdala, hippocampus and cingulated (subgenual and retrospelenial), ventromedial prefrontal cortex. No activations were seen for tactile control stimulations.

Difficult studies because good controls are so difficult. Process of activation of limbic and paralimbic structures may nevertheless be highly important in the therapeutic effect in clinical conditions.

Activation of PAG

Liu et al., 2004 [98]

Mechanical stimulation produced activation in PAG after 20+ min of stimulation.

Activation of endogenous analgesic systems may be part of underlying effects of acupuncture.

Pain Control

Controllability

Salomons et al, 2004 [99]

Control attenuated activation in anterior cingulated and insula.

Cognitive and affective control of pain has enormous implications in clinical aspects of potential painful procedures.

Immediate Control of Brain Activation and Pain

deCharms et al., 2005. [100]

Real time fMRI (rtfMRI) to train subjects to control activation in rACC. Subjects (control and chronic pain) could change activation in ACC with corresponding change in perception to noxious stimuli

First use of rtfMRI in pain.

Perhaps of greatest importance are studies of the placebo effect since there has been a significant literature in this domain from psychophysical studies 4950. A neurobiology and neurocircuitry were predicted for the placebo effect based on its effects on analgesia. 51. Indeed the general circuitry of the placebo response can be applied to non-painful stimuli. These and other studies have enhanced our knowledge of the interaction of physiological pain circuits and cognitive/emotional circuits 52. The use of imaging has now clearly established how some of these endogenous systems operate. This understanding coupled with an objective method of evaluating placebo should provide novel insights into drug development as well as the treatment of patients with acute and chronic pain.

Complementary with fMRI studies on placebo, the use of fMRI has identified neural systems involved in anxiety and fear related to pain. These two reactions to pain are important both from a neuroscience aspect. 16 as well as from practical applications of treating patients. While fear and anxiety have been considered to have different effects on neural processing 53, recent fMRI studies have begun to explore this issue 54.

The innate nature of the pain experience is clearly indicated by studies showing that activations in non-sensory CNS systems in an observer experiencing empathetic pain, are similar to those produced in a subject by noxious stimuli. The study of endogenous analgesia highlights the opponent systems operating in pain. In addition, fMRI studies reveal that in addition to the sensory pathways activated in endogenous analgesia and pain processing, reward/aversion circuitry is activated, with reward related to pain relief and aversion related to pain. 21. The balance between these opponent systems may be crucial in determining the overall sensory and emotional experience of pain in chronic pain states.

fMRI has also been applied to exploring the neurobiology of acupuncture, which is believed to activate endogenous analgesic mechanisms 55. Such studies have predominantly been in healthy subjects using experimental pain. The evidence for the benefit of acupuncture for clinical studies has been mixed. For example, recent studies in migraine patients has indicated that acupuncture may be no more effective than sham acupuncture in reducing migraine headaches, although both are more effective than no intervention. Such studies need to be repeated, but raise questions as to how acupuncture works (for example, through activation of diffuse noxious inhibitory controls or activation of endogenous systems through expectancy etc.) 56. In carefully devised studies, defining brain circuits involved in expectancy, treatment etc. may help provide a more objective evaluation of such interventions.

fMRI Studies of Analgesics

fMRI is also being applied to the evaluation of analgesics (pharmacological MRI or phMRI). 57. Examples are provided in Table 5.

Table 5

Examples of Contributions of fMRI on Analgesics

STUDY FOCUS

REFERENCE

MAJOR FINDINGS

COMMENT

Opioids

Remifentanil(short acting μ opioid)

Wise et al., 2004. [101]

Activation measured in insula to noxious stimulus in subjects receiving Rx.

Study evaluates time course and half life of action of Rx in brain region.

Remifentanil

Wise et al., 2002 [102]

Activation in brain regions to noxious heat stimulus in patients receiving Rx vs. saline. Rx produced decrease in level of pain activation in insula cortex.

First study to Evaluate CNS effects on stimulus; this allowed for extraction of regions most affected by the Rx.

NaloxoneOpioid (μ antagonist)

Borras et al., 2004. [59]

10 subjects. Direct drug effects indicated increased in aCG, prefrontal cortex, hippocampus and entorrhinal cortex. Post infusion painful heat produced increase in activation (correlated with psychophysical effects).

First study on opioids to address direct CNS effects. Naloxone is a drug that has no cognitive effects in normal healthy volunteers.

Morphine (μ agonist)

Becerra 2006. [58]

Low dose morphine produces changes in reward (SLEA, NAc, GOb) endogenous analgesia (PAG), and hypnotic circuits.

fMRI of the effects of morphine on CNS circuits – indicating the use of this approach to define specific circuitry activated by a drug.

Antiseizure meds

Gabapentin

Ianetti et al., 2005 [41]

Healthy volunteers. In a capsaicin model, single dose gabapentin has an antinociceptive effect but a stronger antihyperalgesic effect: the study indicates that the drug is more effective in the sensitized state.

An excellent example of the application of fMRI to drug evaluation in dissecting the value of a model with potential clinical relevance.

Anti-inflammatory

Cyclogoxygenase-2 inhibitor (Cox 2)

Baliki et al., 2005 [61]

Patient with psoriatic arthritis. Single subject evaluation. Activation induced by palpating joints included thalamus, insula, SI, SII, aCG. Rx produced decrease at 1 h.

An example of specific application on evaluating efficacy of Rx. No drug site of action could be detected in this study.

Antidepressant

Amitriptyline

Morgan et al., 2005 [62]

Evaluation of rectal pain in patients with irritable bowel syndrome. Rx produced a decrease in activation in aCG, parietal association cortex.

Another example of how the focus on efficacy (CNS) of drugs may be evaluated.

Analgesic effects on brain systems or neural circuits (stimulus independent) – Many analgesics have direct CNS effects, and very little is known about how they act on the human brain. Such studies are most often performed in healthy volunteers. Here the direct effect of administration of a drug is observed without any stimulus paradigm. These types of studies allow for the interrogation of effects that may not be obvious (e.g., subcortical, subconscious), for integration of how drugs may have a role on intact brain systems that still may be the case in the chronic pain state, and for the evaluation of potential side effects of drugs. Our naloxone and morphine studies (see Table 4; 5859) have taken this approach and indicate the ability to evaluate direct drug effects even when there are no obvious psychophysical effects (naloxone) or well-described side effect profiles (morphine) that can be evaluated based on circuit activation (e.g., reward, sedation or analgesic circuits). 59. The ability to define specific differences

across classes of drugs (e.g., antidepressants, membrane stabilizers, opioids) may not only help focus on common areas of potential mechanisms but also provide information

within different drug classes (e.g., antidepressants – tricyclics vs. serotonin norepinehprine reuptake inhibitors). Advances in this domain should lead to use of standardized fMRI trials for early phase evaluation of pharmacotherapies for pain 60.

Analgesic effects on acute or chronic pain (stimulus-dependent) – In this group, the effect of the drug is evaluated in subjects usually following an applied painful stimulus. A few examples of this type of approach include the studies of cyclooxygenase (cox) inhibitors 61 and amitriptyline 62 in chronic pain conditions and the effects of drugs on capsaicin-induced hyperalgesia (see Table 5). These approaches show that pharmacological evaluation of the CNS effects of drugs is possible, suggesting that fMRI can be used for objective assessments of drug efficacy; until now, all assessments of analgesic efficacy relied on subjective psychophysical measures.

Conclusion

A revolution in the application of a relatively new technology, fMRI, to the field of pain and analgesia is upon us. Within the next half decade, we should begin to see direct benefits in the clinical setting that could range from (a) use of fMRI to evaluate/diagnose a pain condition; (b) use of fMRI to evaluate drug efficacy in responders vs. non-responders; (c) use of fMRI to evaluate novel drug efficacy (the latter will be driven predominantly by the pharmaceutical industry) and (d) use of fMRI to provide new insights into the mechanisms of endogenous 'pain systems'. We believe there is good reason to expect that the contribution of this technology together with advances in other neurosciences will help transition the state of current pain therapy from 'o me miserum!' ('o woe is me!') to more optimistic states for both patient and clinician 'semper aliqud novii' ('always something new' .... and better/useful). We believe there is good reason to expect that the contribution of this technology together with advances in other neurosciences will significantly advance therapies for chronic pain and alleviate physical and emotional suffering for the many individuals living with this disease.

Abbreviation List

aCG – anterior cingulated cortex; CNS – central nervous system; CRPS – complex regional pain syndrome; DNIC – Diffuse noxious inhibitory Controls; GOb – Orbitorfrontal cortex; Hi – Hippocampus; I – Insula; IBS – irritable bowel syndrome; NAc – nucleus accumbens; nCF – cuneiform nucleus; P – putamen; PAG – periaqueductal gray; pCG – posterior cingulated cortex; Rx – treatment; SCI – Spinal cord injury; SI – primary somatosensory cortex; SII – secondary somatosensory cortex; SLEA – sublenticular extended amygdala; SMP – sympathetically maintained pain; TG – trigeminal ganglion; TN – trigeminal nucleus; VAS – visual analogue scale; VMpo – ventromedial nucleus;

Acknowledgements

This work was supported by a Grant to DB from NINDS (NS042721). We would like to thank Sadie Cole, B.A., for her help with the preparation of the manuscript.

Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial.[see comment] Rowbotham M Harden N Stacey B Bernstein P Magnus-Miller L JAMA 1998 280 21 1837 1842 10.1001/jama.280.21.1837 9846778 Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial Lesser H Sharma U LaMoreaux L Poole RM Neurology 2004 63 11 2104 2110 15596757 Morphine, gabapentin, or their combination for neuropathic pain Gilron I Bailey JM Tu D Holden RR Weaver DF Houlden RL N Engl J Med 2005 352 13 1324 1334 10.1056/NEJMoa042580 15800228 Combination pharmacotherapy for neuropathic pain: current evidence and future directions Gilron I Max MB Expert Rev Neurother 2005 5 6 823 830 10.1586/14737175.5.6.823 16274339 Mechanism-based classifications of pain and analgesic drug discovery Woolf CJ Borsook D Koltzenburg M Pain: Current Understanding, Emerging Therpaies, and Novel Approaches to Drug Discovery New York , Marcel Dekker, Inc. C. Bountra RMWKS 2004 1 8 Pain catastrophizing and neural responses to pain among persons with fibromyalgia Gracely RH Geisser ME Giesecke T Grant MA Petzke F Williams DA Clauw DJ Brain 2004 127 Pt 4 835 843 10.1093/brain/awh098 14960499 Prospects for human pharmacological functional magnetic resonance imaging (phMRI) Tracey I J Clin Pharmacol 2001 Suppl 21S 28S 11452725 Utilizing brain imaging for analgesic drug development Borsook D Ploghaus A Becerra L Curr Opin Investig Drugs 2002 3 9 1342 1347 12498011 The neural basis of the blood-oxygen-level-dependent functional magnetic resonance imaging signal Logothetis NK Philos Trans R Soc Lond B Biol Sci 2002 357 1424 1003 1037 10.1098/rstb.2002.1114 12217171 Human brain activation under controlled thermal stimulation and habituation to noxious heat: an fMRI study Becerra LR Breiter HC Stojanovic M Fishman S Edwards A Comite AR Gonzalez RG Borsook D Magn Reson Med 1999 41 5 1044 1057 10.1002/(SICI)1522-2594(199905)41:5<1044::AID-MRM25>3.0.CO;2-M 10332889 Event-related fMRI of pain: entering a new era in imaging pain Davis KD Kwan CL Crawley AP Mikulis DJ Neuroreport 1998 9 13 3019 3023 9804308 Neural correlates of prickle sensation: a percept-related fMRI study Davis KD Pope GE Crawley AP Mikulis DJ Nat Neurosci 2002 5 11 1121 1122 10.1038/nn955 12368810 Dynamics of pain: fractal dimension of temporal variability of spontaneous pain differentiates between pain States Foss JM Apkarian AV Chialvo DR J Neurophysiol 2006 95 2 730 736 10.1152/jn.00768.2005 16282201 Functional imaging of pain and analgesia--a valid diagnostic tool? Borsook D Becerra L Pain 2005 117 3 247 250 10.1016/j.pain.2005.07.006 16154699 Sensory, motivational, and central control determinants of pain Melzack R Casey KL The Skin Senses Springfield, IL , Thomas Kenshalo DR 1968 423 439 Reward-aversion circuitry in analgesia and pain: Implications for psychiatric disorders. Borsook D Becerra L Carlezon W Shaw M Renshaw P Elman I Levine JA European Journal of Pain 2005 In press Reward circuitry activation by noxious thermal stimuli Becerra L Breiter HC Wise R Gonzalez RG Borsook D Neuron 2001 32 5 927 946 10.1016/S0896-6273(01)00533-5 11738036 Noxious heat induces fMRI activation in two anatomically distinct clusters within the nucleus accumbens Aharon I Becerraa L Chabris CF Borsooka D Neurosci Lett 2006 392 3 159 164 10.1016/j.neulet.2005.09.054 16257488 Somatotopic organisation of the human insula to painful heat studied with high resolution functional imaging Brooks JC Zambreanu L Godinez A Craig AD Tracey I Neuroimage 2005 27 1 201 209 10.1016/j.neuroimage.2005.03.041 15921935 Somatotopic activation in the human trigeminal pain pathway DaSilva AF Becerra L Makris N Strassman AM Gonzalez RG Geatrakis N Borsook D J Neurosci 2002 22 18 8183 8192 12223572 Opponent appetitive-aversive neural processes underlie predictive learning of pain relief Seymour B O'Doherty JP Koltzenburg M Wiech K Frackowiak R Friston K Dolan R Nat Neurosci 2005 8 9 1234 1240 10.1038/nn1527 16116445 Neurophysiological architecture of functional magnetic resonance images of human brain Salvador R Suckling J Coleman MR Pickard JD Menon D Bullmore E Cereb Cortex 2005 15 9 1332 1342 10.1093/cercor/bhi016 15635061 Investigating the neural basis for functional and effective connectivity. Application to fMRI Horwitz B Warner B Fitzer J Tagamets MA Husain FT Long TW Philos Trans R Soc Lond B Biol Sci 2005 360 1457 1093 1108 10.1098/rstb.2005.1647 16087450 Dealing with the shortcomings of spatial normalization: Multi-subject parcellation of fMRI datasets Thirion B Flandin G Pinel P Roche A Ciuciu P Poline JB Hum Brain Mapp 2005 678 693 Functional parcellation of attentional control regions of the brain Woldorff MG Hazlett CJ Fichtenholtz HM Weissman DH Dale AM Song AW J Cogn Neurosci 2004 16 1 149 165 10.1162/089892904322755638 15006044 Functional-anatomical validation and individual variation of diffusion tractography-based segmentation of the human thalamus Johansen-Berg H Behrens TE Sillery E Ciccarelli O Thompson AJ Smith SM Matthews PM Cereb Cortex 2005 15 1 31 39 10.1093/cercor/bhh105 15238447 Dissociating pain from its anticipation in the human brain Ploghaus A Tracey I Gati JS Clare S Menon RS Matthews PM Rawlins JN Science 1999 284 5422 1979 1981 10.1126/science.284.5422.1979 10373114 Exacerbation of pain by anxiety is associated with activity in a hippocampal network Ploghaus A Narain C Beckmann CF Clare S Bantick S Wise R Matthews PM Rawlins JN Tracey I J Neurosci 2001 21 24 9896 9903 11739597 Neural circuitry underlying pain modulation: expectation, hypnosis, placebo Ploghaus A Becerra L Borras C Borsook D Trends Cogn Sci 2003 7 5 197 200 10.1016/S1364-6613(03)00061-5 12757820 Human brain mechanisms of pain perception and regulation in health and disease Apkarian AV Bushnell MC Treede RD Zubieta JK Eur J Pain 2005 9 4 463 484 10.1016/j.ejpain.2004.11.001 15979027 Evidence of augmented central pain processing in idiopathic chronic low back pain Giesecke T Gracely RH Grant MA Nachemson A Petzke F Williams DA Clauw DJ Arthritis Rheum 2004 50 2 613 623 10.1002/art.20063 14872506 Central representation of visceral and cutaneous hypersensitivity in the irritable bowel syndrome Verne GN Himes NC Robinson ME Gopinath KS Briggs RW Crosson B Price DD Pain 2003 103 1-2 99 110 10.1016/S0304-3959(02)00416-5 12749964 Dissecting drug efficacy for neuropathic pain in healthy subjects.: November. Becerra L Pendse G Korn J Shaw M Gostic JM Sherman S Gostic R Borsook D 2005 Chronic back pain is associated with decreased prefrontal and thalamic gray matter density Apkarian AV Sosa Y Sonty S Levy RM Harden RN Parrish TB Gitelman DR J Neurosci 2004 24 46 10410 10415 10.1523/JNEUROSCI.2541-04.2004 15548656 Human surrogate models of neuropathic pain Klein T Magerl W Rolke R Treede RD Pain 2005 115 3 227 233 15876495 Pain-like behaviours in animals - how human are they? Blackburn-Munro G Trends Pharmacol Sci 2004 25 6 299 305 10.1016/j.tips.2004.04.008 15165744 What should we be measuring in behavioral studies of chronic pain in animals? Mogil JS Crager SE Pain 2004 112 1-2 12 15 10.1016/j.pain.2004.09.028 15494180 Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin LaMotte RH Lundberg LE Torebjork HE J Physiol 1992 448 749 764 1176226 1593488 Cortical reorganization during recovery from complex regional pain syndrome Maihofner C Handwerker HO Neundorfer B Birklein F Neurology 2004 63 4 693 701 15326245 Differential coding of hyperalgesia in the human brain: a functional MRI study Maihofner C Handwerker HO Neuroimage 2005 28 4 996 1006 10.1016/j.neuroimage.2005.06.049 16112876 Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans Iannetti GD Zambreanu L Wise RG Buchanan TJ Huggins JP Smart TS Vennart W Tracey I Proc Natl Acad Sci U S A 2005 102 50 18195 18200 1306794 16330766 10.1073/pnas.0506624102 Pain modulation: expectation, opioid analgesia and virtual pain Fields HL Prog Brain Res 2000 122 245 253 10737063 Bad news from the brain: descending 5-HT pathways that control spinal pain processing Suzuki R Rygh LJ Dickenson AH Trends Pharmacol Sci 2004 25 12 613 617 10.1016/j.tips.2004.10.002 15530638 Descending control of pain Millan MJ Prog Neurobiol 2002 66 6 355 474 10.1016/S0301-0082(02)00009-6 12034378 Isolating the modulatory effect of expectation on pain transmission: a functional magnetic resonance imaging study Keltner JR Furst A Fan C Redfern R Inglis B Fields HL J Neurosci 2006 26 16 4437 4443 10.1523/JNEUROSCI.4463-05.2006 16624963 Imaging attentional modulation of pain in the periaqueductal gray in humans Tracey I Ploghaus A Gati JS Clare S Smith S Menon RS Matthews PM J Neurosci 2002 22 7 2748 2752 11923440 Distraction modulates connectivity of the cingulo-frontal cortex and the midbrain during pain--an fMRI analysis Valet M Sprenger T Boecker H Willoch F Rummeny E Conrad B Erhard P Tolle TR Pain 2004 109 3 399 408 10.1016/j.pain.2004.02.033 15157701 Perceptual illusion of "paradoxical heat" engages the insular cortex Davis KD Pope GE Crawley AP Mikulis DJ J Neurophysiol 2004 92 2 1248 1251 10.1152/jn.00084.2004 15277602 Placebo-induced changes in FMRI in the anticipation and experience of pain Wager TD Rilling JK Smith EE Sokolik A Casey KL Davidson RJ Kosslyn SM Rose RM Cohen JD Science 2004 303 5661 1162 1167 10.1126/science.1093065 14976306 Cortical correlates of false expectations during pain intensity judgments--a possible manifestation of placebo/nocebo cognitions Lorenz J Hauck M Paur RC Nakamura Y Zimmermann R Bromm B Engel AK Brain Behav Immun 2005 19 4 283 295 10.1016/j.bbi.2005.03.010 15890494 Biology of placebo analgesia Fields HL Levine JD Am J Med 1981 70 4 745 746 10.1016/0002-9343(81)90525-8 7211908 Using fMRI to dissociate sensory encoding from cognitive evaluation of heat pain intensity Kong J White NS Kwong KK Vangel MG Rosman IS Gracely RH Gollub RL Hum Brain Mapp 2005 715 721 The Neuropsychology of Anxiety: An Enquiry into the Functions of the Septo-Hippocampal System Gray JAMNN Oxford Psychology Series Oxford , Oxford University Press N.J. Mackintosh TSATJLMGDSLW 2nd 2000 33 424 Neural correlates of individual differences in pain-related fear and anxiety Ochsner KN Ludlow DH Knierim K Hanelin J Ramachandran T Glover GC Mackey SC Pain 2006 120 1-2 69 77 10.1016/j.pain.2005.10.014 16364548 Neurobiology of Acupuncture: Toward CAM Ma SX Evid Based Complement Alternat Med 2004 1 1 41 47 442119 15257325 10.1093/ecam/neh017 The organization and function of endogenous antinociceptive systems Sandkuhler J Prog Neurobiol 1996 50 1 49 81 10.1016/0301-0082(96)00031-7 8931107 Human pharmacological MRI Honey G Bullmore E Trends Pharmacol Sci 2004 25 7 366 374 10.1016/j.tips.2004.05.009 15219979 Functional magnetic resonance imaging measures of the effects of morphine on central nervous system circuitry in opioid-naive healthy volunteers Becerra L Harter K Gonzalez RG Borsook D Anesth Analg 2006 103 1 208 16, table of contents 10.1213/01.ane.0000221457.71536.e0 16790655 fMRI measurement of CNS responses to naloxone infusion and subsequent mild noxious thermal stimuli in healthy volunteers Borras MC Becerra L Ploghaus A Gostic JM DaSilva A Gonzalez RG Borsook D J Neurophysiol 2004 91 6 2723 2733 10.1152/jn.00249.2003 15136603 I spy fMRI: To be or not to be in drug development Borsook D Becerra L Hargreaves RA Nature Reviews Drug Discovery under review 16604100 Single subject pharmacological-MRI (phMRI) study: modulation of brain activity of psoriatic arthritis pain by cyclooxygenase-2 inhibitor Baliki M Katz J Chialvo DR Apkarian AV Mol Pain 2005 1 32 1291397 16266429 10.1186/1744-8069-1-32 Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome Morgan V Pickens D Gautam S Kessler R Mertz H Gut 2005 54 5 601 607 10.1136/gut.2004.047423 15831901 Specific and somatotopic functional magnetic resonance imaging activation in the trigeminal ganglion by brush and noxious heat Borsook D DaSilva AF Ploghaus A Becerra L J Neurosci 2003 23 21 7897 7903 12944520 Functional MR imaging of regional brain activation associated with the affective experience of pain Fulbright RK Troche CJ Skudlarski P Gore JC Wexler BE AJR Am J Roentgenol 2001 177 5 1205 1210 11641204 A comparison of visceral and somatic pain processing in the human brainstem using functional magnetic resonance imaging Dunckley P Wise RG Fairhurst M Hobden P Aziz Q Chang L Tracey I J Neurosci 2005 25 32 7333 7341 10.1523/JNEUROSCI.1100-05.2005 16093383 Somatotopic representation of nociceptive information in the putamen: an event-related fMRI study Bingel U Glascher J Weiller C Buchel C Cereb Cortex 2004 14 12 1340 1345 10.1093/cercor/bhh094 15217895 Learning about pain: the neural substrate of the prediction error for aversive events Ploghaus A Tracey I Clare S Gati JS Rawlins JN Matthews PM Proc Natl Acad Sci U S A 2000 97 16 9281 9286 16859 10908676 10.1073/pnas.160266497 Representations of pleasant and painful touch in the human orbitofrontal and cingulate cortices Rolls ET O'Doherty J Kringelbach ML Francis S Bowtell R McGlone F Cereb Cortex 2003 13 3 308 317 10.1093/cercor/13.3.308 12571120 An fMRI study of cortical representation of mechanical allodynia in patients with neuropathic pain Peyron R Schneider F Faillenot I Convers P Barral FG Garcia-Larrea L Laurent B Neurology 2004 63 10 1838 1846 15557499 Trigeminal Neuropathic Pain Alters Responses in CNS Circuits to Mechanical (brush) and Thermal (cold and heat) Stimuli Becerra L Morris S Bazes S Gostic R Sherman S Gostic J Pendse G Moulton E Scrivani S Keith D Chizh B Borsook D J Neurosci 2006 Emotional and autonomic consequences of spinal cord injury explored using functional brain imaging Nicotra A Critchley HD Mathias CJ Dolan RJ Brain 2005 16330503 Unpleasant odors increase pain processing in a patient with neuropathic pain: Psychophysical and fMRI investigation Villemure C Wassimi S Bennett GJ Shir Y Bushnell MC Pain 2006 120 1-2 213 220 10.1016/j.pain.2005.10.031 16361059 fMRI of mechanical allodynia in children with complex regional (leg) pain syndrome (CRPS). Lebel A Becerra L Waring M Morris S Pendse G Grant E Moulton E Berde C Borsook D Soc Neuroscience 2005 Prefrontal cortical hyperactivity in patients with sympathetically mediated chronic pain Apkarian AV Thomas PS Krauss BR Szeverenyi NM Neurosci Lett 2001 311 3 193 197 10.1016/S0304-3940(01)02122-X 11578827 Functional imaging of pain in patients with primary fibromyalgia Cook DB Lange G Ciccone DS Liu WC Steffener J Natelson BH J Rheumatol 2004 31 2 364 378 14760810 Abnormal forebrain activity in functional bowel disorder patients with chronic pain Kwan CL Diamant NE Pope G Mikula K Mikulis DJ Davis KD Neurology 2005 65 8 1268 1277 10.1212/01.wnl.0000180971.95473.cc 16247056 Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls Wilder-Smith CH Schindler D Lovblad K Redmond SM Nirkko A Gut 2004 53 11 1595 1601 10.1136/gut.2003.028514 15479679 Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention Mertz H Morgan V Tanner G Pickens D Price R Shyr Y Kessler R Gastroenterology 2000 118 5 842 848 10.1016/S0016-5085(00)70170-3 10784583 Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study Bonaz B Baciu M Papillon E Bost R Gueddah N Le Bas JF Fournet J Segebarth C Am J Gastroenterol 2002 97 3 654 661 10.1111/j.1572-0241.2002.05545.x 11926209 Neural correlates of painful genital touch in women with vulvar vestibulitis syndrome Pukall CF Strigo IA Binik YM Amsel R Khalife S Bushnell MC Pain 2005 115 1-2 118 127 10.1016/j.pain.2005.02.020 15836975 Brain processing of capsaicin-induced secondary hyperalgesia: a functional MRI study Baron R Baron Y Disbrow E Roberts TP Neurology 1999 53 3 548 557 10449119 A role for the brainstem in central sensitisation in humans. Evidence from functional magnetic resonance imaging Zambreanu L Wise RG Brooks JC Iannetti GD Tracey I Pain 2005 114 3 397 407 10.1016/j.pain.2005.01.005 15777865 Modulation of pain processing in hyperalgesia by cognitive demand Wiech K Seymour B Kalisch R Stephan KE Koltzenburg M Driver J Dolan RJ Neuroimage 2005 27 1 59 69 10.1016/j.neuroimage.2005.03.044 15978845 Placebo in emotional processing--induced expectations of anxiety relief activate a generalized modulatory network Petrovic P Dietrich T Fransson P Andersson J Carlsson K Ingvar M Neuron 2005 46 6 957 969 10.1016/j.neuron.2005.05.023 15953423 Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network Bingel U Lorenz J Schoell E Weiller C Buchel C Pain 2006 120 1-2 8 15 10.1016/j.pain.2005.08.027 16364549 Imaging how attention modulates pain in humans using functional MRI Bantick SJ Wise RG Ploghaus A Clare S Smith SM Tracey I Brain 2002 125 Pt 2 310 319 10.1093/brain/awf022 11844731 Modulation of thermal pain-related brain activity with virtual reality: evidence from fMRI Hoffman HG Richards TL Coda B Bills AR Blough D Richards AL Sharar SR Neuroreport 2004 15 8 1245 1248 15167542 Attention to pain localization and unpleasantness discriminates the functions of the medial and lateral pain systems Kulkarni B Bentley DE Elliott R Youell P Watson A Derbyshire SW Frackowiak RS Friston KJ Jones AK Eur J Neurosci 2005 21 11 3133 3142 10.1111/j.1460-9568.2005.04098.x 15978022 Empathy for pain involves the affective but not sensory components of pain Singer T Seymour B O'Doherty J Kaube H Dolan RJ Frith CD Science 2004 303 5661 1157 1162 10.1126/science.1093535 14976305 Neuroscience. Feeling the pain of social loss Panksepp J Science 2003 302 5643 237 239 10.1126/science.1091062 14551424 Neural correlates of the prolonged salience of painful stimulation Downar J Mikulis DJ Davis KD Neuroimage 2003 20 3 1540 1551 10.1016/S1053-8119(03)00407-5 14642466 Expectation of pain enhances responses to nonpainful somatosensory stimulation in the anterior cingulate cortex and parietal operculum/posterior insula: an event-related functional magnetic resonance imaging study Sawamoto N Honda M Okada T Hanakawa T Kanda M Fukuyama H Konishi J Shibasaki H J Neurosci 2000 20 19 7438 7445 11007903 The subjective experience of pain: where expectations become reality Koyama T McHaffie JG Laurienti PJ Coghill RC Proc Natl Acad Sci U S A 2005 102 36 12950 12955 1200254 16150703 10.1073/pnas.0408576102 Does anticipation of pain affect cortical nociceptive systems? Porro CA Baraldi P Pagnoni G Serafini M Facchin P Maieron M Nichelli P J Neurosci 2002 22 8 3206 3214 11943821 Cerebral activation during hypnotically induced and imagined pain Derbyshire SW Whalley MG Stenger VA Oakley DA Neuroimage 2004 23 1 392 401 10.1016/j.neuroimage.2004.04.033 15325387 Altered central somatosensory processing in chronic pain patients with "hysterical" anesthesia Mailis-Gagnon A Giannoylis I Downar J Kwan CL Mikulis DJ Crawley AP Nicholson K Davis KD Neurology 2003 60 9 1501 1507 12743239 Effects of electroacupuncture versus manual acupuncture on the human brain as measured by fMRI Napadow V Makris N Liu J Kettner NW Kwong KK Hui KK Hum Brain Mapp 2005 24 3 193 205 10.1002/hbm.20081 15499576 fMRI study of acupuncture-induced periaqueductal gray activity in humans Liu WC Feldman SC Cook DB Hung DL Xu T Kalnin AJ Komisaruk BR Neuroreport 2004 15 12 1937 1940 10.1097/00001756-200408260-00021 15305141 Perceived controllability modulates the neural response to pain Salomons TV Johnstone T Backonja MM Davidson RJ J Neurosci 2004 24 32 7199 7203 10.1523/JNEUROSCI.1315-04.2004 15306654 Control over brain activation and pain learned by using real-time functional MRI deCharms RC Maeda F Glover GH Ludlow D Pauly JM Soneji D Gabrieli JD Mackey SC Proc Natl Acad Sci U S A 2005 102 51 18626 18631 1311906 16352728 10.1073/pnas.0505210102 Using fMRI to quantify the time dependence of remifentanil analgesia in the human brain Wise RG Williams P Tracey I Neuropsychopharmacology 2004 29 3 626 635 10.1038/sj.npp.1300364 14679387 Combining fMRI with a pharmacokinetic model to determine which brain areas activated by painful stimulation are specifically modulated by remifentanil Wise RG Rogers R Painter D Bantick S Ploghaus A Williams P Rapeport G Tracey I Neuroimage 2002 16 4 999 1014 10.1006/nimg.2002.1146 12202088